Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY) Stock Price & Analysis
Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY) closed at USD 14.34 on Thursday, October 22, 2026, up 15.43% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 12.42; the Oct 22, 2026 session ranged USD 15.48–15.48 on volume of 6 shares. Market capitalization is $11.93B, with a 52-week range of USD 9.29–17.16 (PNK). Source: Nexqual, retrieved October 23, 2026 at 16:40 UTC.
Also available as compact Markdown for AI agents: nexqual.com/RICFY.md
Key facts (RICFY)
- Analysts: None.
- Total return with dividends: 1Y -0.1% vs S&P 500 +14.6%; 5Y +30.2% vs S&P 500 +77.3%.
Analysts (RICFY)
Consensus None.
Total return (dividends reinvested) (RICFY)
| 1Y (from 2025-10-23) | 5Y (from 2023-11-27) | |
|---|---|---|
| Total return | -0.1% | +30.2% |
| S&P 500 (SPY) | +14.6% | +77.3% |
| Per year | -0.1% | +9.5% |
| Volatility (annualized) | 96.0% | 50.1% |
| Max drawdown | -33.1% (Apr 2026→May 2026) | -33.3% (Jul 2025→May 2026) |
RICFY analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | — | — | — | $674.4M | — |
| Next quarter (ends Dec 2026) | — | — | — | $684.8M | — |
| Current fiscal year (ends Dec 2026) | — | — | — | $2.79B | — |
| Next fiscal year (ends Dec 2027) | — | — | — | $3.03B | — |
Key Statistics (as of October 23, 2026 at 16:40 UTC)
| Price | USD 14.34 |
|---|---|
| Change | ▲ 15.43% (up) |
| Previous Close | USD 12.42 |
| Open | USD 15.48 |
| Day Range | USD 15.48 – 15.48 |
| 52-Week Range | USD 9.29 – 17.16 |
| Volume | 6 shares |
| Market Cap | $11.93B |
| Exchange | PNK |
Technical Analysis (RICFY)
Nexqual's technical model rates RICFY "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 16:40 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 46.59 (neutral) |
| vs SMA50 | Below (USD 14.82) |
| MACD | -0.3 (negative) |
Analyst Ratings (RICFY)
Wall Street analysts rate RICFY "None", per Nexqual as of October 23, 2026 at 16:40 UTC.
| Consensus Rating | None |
|---|
Earnings (RICFY)
| Revenue Estimate | $674.40M |
|---|
Source: Nexqual, October 23, 2026 at 16:40 UTC.
Financials & Fundamentals (RICFY)
| Total Revenue | $2.71B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +8.30% |
| Gross Margin | +71.48% |
| Operating Margin | +29.20% |
| Profit Margin | +18.38% |
| ROE | +24.85% |
| Debt / Equity | 1.09 |
| Current Ratio | 1.26 |
| Total Cash | $391.38M |
| Total Debt | $2.31B |
Source: Nexqual, October 23, 2026 at 16:40 UTC.
Financial Health Score (RICFY)
Nexqual rates Recordati Industria Chimica e Farmaceutica S.p.A.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 16:40 UTC.
| Growth | Solid — Revenue +12% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 71%, operating 29% (last 12 months) |
| Balance Sheet | Mixed — EUR 391M cash vs EUR 2.31B debt |
| Cash Flow | Solid — Operating cash flow EUR 645M (TTM) |
| Efficiency | Strong — ROE 25%, ROA 9.8% |
Ownership (RICFY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 832.00M |
| Float | 407.47M |
Source: Nexqual, October 23, 2026 at 16:40 UTC.
Leadership (RICFY)
Recordati Industria Chimica e Farmaceutica S.p.A. is led by Robert Koremans, CEO & Director, per Nexqual as of October 23, 2026 at 16:40 UTC.
| CEO & Director | Robert Koremans |
|---|---|
| Executive Director | Cathrin Petty |
| Executive Director | Giampiero Mazza |
| Chief Financial Officer | Michael McClellan |
| Group Communications Director | Laura Conti |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GRFS | Grifols, S.A. | USD 7.55 | ▲ 1.28% |
| BIIB | Biogen Inc. | USD 250.61 | ▼ 1.27% |
| OGN | Organon & Co. | USD 13.76 | ▲ 0.07% |
| SNY | Sanofi | USD 41.5 | ▼ 1.1% |
| GSK | GSK plc | USD 50.63 | ▼ 1.13% |
| BMY | Bristol-Myers Squibb Company | USD 61.79 | ▼ 1.93% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 16:40 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt